MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.27
-0.87 (-7.81%)
May 13, 2025, 4:00 PM - Market closed

MBX Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
May '25 Dec '24 Dec '23 Dec '22
Market Capitalization
343616--
Enterprise Value
103339--
Last Close Price
10.2718.43--
Debt / Equity Ratio
0.000.000.000.01
Quick Ratio
23.1123.7820.6012.42
Current Ratio
23.3124.1921.2612.89
Return on Equity (ROE)
-48.22%-36.71%-53.75%-
Return on Assets (ROA)
-31.68%-24.17%-34.14%-
Return on Capital (ROIC)
-33.35%-25.23%-36.20%-
Buyback Yield / Dilution
-1591.64%-944.70%-52.73%-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q